Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune Microenvironment

12 Oct 2021

Abstract excerpt

The prognosis of patients with endometrial cancer (EC) is closely associated with immune cell infiltration. Although abnormal long non-coding RNA (lncRNA) expression is also linked to poor prognosis in patients with EC, the function and action mechanism of immune infiltration-related lncRNAs underlying the occurrence and development of EC remains unclear. In this study, we analyzed lncRNA expression using The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Circular RNAs in diseases
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34712660
DOI: 10.3389/fcell.2021.721676

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune MicroenvironmentPMID 34712660Read ↗

An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial CancerSemantic proximity Read ↗

Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironmentSemantic proximity Read ↗

A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial CancerSemantic proximity Read ↗

N6-methylandenosine-related lncRNAs have the prognostic predictive ability for patients with Endometrial CancerSemantic proximity Read ↗

Mining of clinical and prognosis related genes in the tumor microenvironment of endometrial cancerSemantic proximity Read ↗

Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.Semantic proximity Read ↗

Development and validation of m6A regulators’ prognostic significance for endometrial cancerSemantic proximity Read ↗

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.Semantic proximity Read ↗

Identifying immune subtypes of uterine corpus endometrial carcinoma and a four-paired-lncRNA signature with immune-related lncRNAs.Semantic proximity Read ↗

Integrated analysis of immune-related genes in endometrial carcinomaSemantic proximity Read ↗

Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.